Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Yokose

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Leukemia & Lymphoma|March 14, 1998
Plasma soluble interleukin-2 receptors in patients with myelodysplastic syndromesN Yokose, K Ogata
Leukemia & Lymphoma|May 1, 1995
Interleukin-2 therapy for myelodysplastic syndrome: does it work?K Ogata, N Yokose, T Nomura
International Journal of Hematology|August 1, 1994
Aplastic anemia with circulating erythroblastsN Yokose, K Ogata, K Dan, et al.
Stem Cells (Dayton, Ohio)|April 1, 2000
Effect of thrombopoietin on proliferation of blasts from patients with myelodysplastic syndromesS S Luo, K Ogata, N Yokose, et al.
Leukemia Research|February 1, 1993
Effects of interleukin 2 on myelodysplastic syndromesK Ogata, N Yokose, T Ito, et al.
Clinical Immunology and Immunopathology|September 1, 1997
Natural killer cells in the late decades of human lifeK Ogata, N Yokose, H Tamura, et al.
Annals of Hematology|March 1, 1995
Lineage-unrestricted hematologic response to granulocyte colony-stimulating factor in a patient with refractory anemia with excess blastsN Yokose, K Ogata, E An, et al.
Experimental Hematology|January 1, 1997
Cell cycle modulation by hematopoietic growth factors in myelodysplastic syndromes: analysis by three-color flow cytometryK Ogata, E An, K Kamikubo, et al.
Annals of Hematology|July 28, 2001
CD20-positive T cell leukemia/lymphoma: case report and review of the literatureN Yokose, K Ogata, Y Sugisaki, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1993
A novel megakaryocyte potentiator produced by MC-1 human lung cancer cell lineS Kuriya, K Ogata, E An, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|March 14, 1998
Plasma soluble interleukin-2 receptors in patients with myelodysplastic syndromesN Yokose, K Ogata
Leukemia & Lymphoma|May 1, 1995
Interleukin-2 therapy for myelodysplastic syndrome: does it work?K Ogata, N Yokose, T Nomura
International Journal of Hematology|August 1, 1994
Aplastic anemia with circulating erythroblastsN Yokose, K Ogata, K Dan, et al.
Stem Cells (Dayton, Ohio)|April 1, 2000
Effect of thrombopoietin on proliferation of blasts from patients with myelodysplastic syndromesS S Luo, K Ogata, N Yokose, et al.
Leukemia Research|February 1, 1993
Effects of interleukin 2 on myelodysplastic syndromesK Ogata, N Yokose, T Ito, et al.
Clinical Immunology and Immunopathology|September 1, 1997
Natural killer cells in the late decades of human lifeK Ogata, N Yokose, H Tamura, et al.
Annals of Hematology|March 1, 1995
Lineage-unrestricted hematologic response to granulocyte colony-stimulating factor in a patient with refractory anemia with excess blastsN Yokose, K Ogata, E An, et al.
Experimental Hematology|January 1, 1997
Cell cycle modulation by hematopoietic growth factors in myelodysplastic syndromes: analysis by three-color flow cytometryK Ogata, E An, K Kamikubo, et al.
Annals of Hematology|July 28, 2001
CD20-positive T cell leukemia/lymphoma: case report and review of the literatureN Yokose, K Ogata, Y Sugisaki, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1993
A novel megakaryocyte potentiator produced by MC-1 human lung cancer cell lineS Kuriya, K Ogata, E An, et al.
Pageof 3